Blood cancer drug helped severely ill COVID-19 patients come off supplemental oxygen and ventilator
A blood cancer drug may help improve the conditions of severely ill coronavirus patients, a new small study suggests. Acalabrutinib, sold under the brandname Calquence by AstraZeneca, is a medication with anti-inflammatory properties that scientists believe can control the immune system’s overreaction to the virus. The majority of patients given the drugs came off supplemental … Read more